Brain scan breakthrough: new tracer could catch Parkinson's early

NCT ID NCT06738862

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This completed study tested a new radioactive tracer called [18F] - FD17 for PET imaging to detect clumps of a protein called alpha-synuclein in the brain. These clumps are linked to Parkinson's disease, multiple system atrophy, and a sleep disorder that often precedes Parkinson's. Researchers scanned 55 people, including healthy volunteers and patients, to see if the tracer could help diagnose these conditions earlier and more accurately. The goal is to improve early detection and diagnosis of neurodegenerative diseases.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
[18F] - FD17 (a radioactive imaging agent used in PET scans)
What this could lead to
If successful, this imaging method could allow doctors to detect Parkinson's and related diseases earlier and more accurately, potentially before symptoms worsen.
What could go wrong
This is a small, completed imaging study, not a treatment trial. The agent may not reliably distinguish between different diseases, and further larger studies are needed to confirm its usefulness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SYSTEM ATROPHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

    Shanghai, Shanghai Municipality, 200025, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.